Code and data for Keynote 522 economic model

Published: 1 June 2023| Version 2 | DOI: 10.17632/ct4mpzbx93.2
Contributor:
David Epstein

Description

Economic evaluation of pembrolizumab for early triple negative breast cancer: R code for choosing appropriate parametric survival function (choose_flexsurv.r) R code for estimating hazards of progression (Digitalizacion pembro.r) R code for digitalization of observed Kaplan Meier (Funcion_guyot_1.r) CSV files containing coordinates of Kaplan Meier curves from the Keynote 522 study (N Engl J Med 2020;382:810-21. DOI: 10.1056/NEJMoa1910549) Markov Model comparing pembrolizumab to no pembrolizumab (modelo_v3.xlsm)

Files

Institutions

Universidad de Granada - Campus de Cartuja

Categories

Software, Breast Cancer, Pembrolizumab, Economic Evaluation

Licence